Spain· ES:58113
PLURIMEN 5 mg COMPRIMIDOS
A medicinal product containing selegilina, registered in Spain by Orion Corporation.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- selegilina
- Manufacturer
- Orion Corporation
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo66330750EUR 11.13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Selegilina in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEldepryl 5mg tabletsOrion Pharma (UK) Ltd
- United StatesSelegiline HydrochlorideA2A Integrated Pharmaceuticals
- FinlandEldeprylParanova Oy
- ItalyJUMEXCHIESI ITALIA S.P.A.
- NorwayEldeprylOrion Corporation
- SwedenEldepryl 5 mg TablettOrion Corporation
- IrelandEldepryl 5 mg TabletsOrion Corporation
- CzechiaSELEGOS
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Eldepryl
- Bulgaria · Jamax, Селегос
- Cyprus · Selegos, Selex
- Germany · Selegilin Neuraxpharm
- Denmark · Eldepryl
- Finland · Eldepryl
- France · Deprenyl
- United Kingdom (Northern Ireland) · Eldepryl, Selegiline Hydrochloride Activase Pharmaceuticals
- Greece · Feliselin
- Ireland · Eldepryl
- Italy · Jumex, Selecom
- Luxembourg · Eldepryl
- Latvia · Eldepryl
- Norway · Eldepryl
- Poland · Selgres
- Portugal · Selegilina Generis
- Romania · Selegos
- Sweden · Eldepryl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eaf00de2-3477-4641-a3ff-bcc0a20cf73a GET /v1/drugs/eaf00de2-3477-4641-a3ff-bcc0a20cf73a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":599612400000}",
"nregistro": "58113",
"substance": "selegilina"
}See everything about selegilina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.